The Week Ahead: Fed...
AtriCure Inc. (ATRC: NASDAQ)
$8.80 -0.19 | -2.11%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 8.80 |
| 52 Week High | 14.84 |
| 52 Week Low | 7.87 |
| Avg. Daily Vol. (Mil) | 0.05 |
| Beta (3 year) | 0.51 |
| Share Related Items | |
| Mkt Cap (Mil) | 145.08 |
| Shares Out (Mil) | 16.49 |
| Float (Mil) | 10.52 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.10 |
| Current Ratio | 2.80 |
| LT Debt/ Equity | 0.54 |
| Total Debt / Equity | 0.68 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 2.19 |
| Price/Book | 9.90 |
| Price/Cash Flow | -38.80 |
| Per Share Data | |
| Earnings | -0.36 |
| Sales | 4.02 |
| Book Value | 0.89 |
| Cash Flow | -0.23 |
| Business Summary | |
|---|---|
| AtriCure, Inc. is a medical device company, which develops, manufactures and sells innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. | |
| General Information | |
| 6217 Centre Park Drive
West Chester, OH 45069 |
|
| www.atricure.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 240 | |
| CEO: David J. Drachman | |
| Short Interest | |
| Current Month (Mil) | 0.47 |
| Previous Month (Mil) | 0.46 |
| Short Interest Ratio (Days) | 7.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -15.90 |
| Return on Investments | -25.00 |
| Profitability | |
| Gross Margin | 75.40 |
| EBIT Margin | -7.60 |
| Profit Margin | -8.80 |
Portfolios with ATRC
- Portfolio NameUser Type
- ContributorBarrington's Best Stock Pic...
- ContributorBarrington's Updated Best S...
- Userfjknight Portfolio 1
- UserRAPTOR SPRTD RED -0311081629
- Useramarmaharaj Portfolio 1
- UserBarron's Research Reports 5...
- Userralphmalph Portfolio 1
- Useryvebee1
- UserSmall Cap Healthcare
Latest ATRC Headlines from TheStreet
- AtriCure's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 04:05 pm
- AtriCure's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.27.12 | 07:02 pm
- Barrington's Best Stock Picks for 2012 01.12.12 | 05:01 am
- AtriCure Update On DEEP AF Feasibility Trial - Call Transcript 12.11.11 | 04:12 pm
- AtriCure's CEO Hosts Update Call On DEEP AF Feasibility Trial - Conference Call Transcript 12.11.11 | 04:12 pm
- AtriCure's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.01.11 | 05:11 pm
- AtriCure's CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.02.11 | 05:08 pm
- AtriCure CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.04.11 | 03:05 pm
- Barrington Updates Best Stock Picks for 2011 04.12.11 | 06:04 am
- AtriCure, Inc. CEO Discusses Q4 2010 Results - Earnings Call Transcript 02.16.11 | 03:02 pm
Press Releases for ATRC
- AtriCure Reports First Quarter 2012 Financial Results - Business Wire 05.02.12 | 04:05 pm
- AtriCure To Announce First Quarter 2012 Financial Results - Business Wire 04.23.12 | 09:04 am
- AtriCure To Present At 24th Annual Roth Conference - Business Wire 03.06.12 | 08:03 am
- AtriCure Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.27.12 | 04:02 pm
- AtriCure To Announce Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.21.12 | 03:02 pm
- AtriCure Announces February Investor Conference Schedule - Business Wire 02.09.12 | 12:02 pm
- AtriCure’s Synergy Ablation System Receives FDA Approval For The Treatment Of Atrial Fibrillation - Business Wire 12.16.11 | 08:12 am
- Update On AtriCure’s DEEP AF Feasibility Trial - Business Wire 11.17.11 | 08:11 am
- AtriCure Announces Upcoming Investor Conference Schedule - Business Wire 11.10.11 | 11:11 am
- AtriCure Reports Third Quarter 2011 Financial Results - Business Wire 11.01.11 | 08:11 am
Partner Headlines for ATRC
- Piper Jaffray Gives Insight to Medical Technology Industry Overview - Benzinga 01.17.12 | 09:01 am
- Will Barrington's Best Stock Picks for 2011 Deliver? - Seeking Alpha 04.18.11 | 07:04 am
- UPDATE 1-AtriCure's heart device gets FDA approval; shares up - Reuters 06.14.10 | 05:06 pm





